Literature DB >> 29915169

Behçet's disease: minireview with emphasis on oral aspects.

Luca Giannetti1, Alberto Murri Dello Diago2, Lorenzo Lo Muzio3.   

Abstract

Adamatiades-Behçet disease (BD) is a primary systemic vasculitis of unknown origin, that may involve blood vessels of all sizes. The clinical hall-mark of the disease are recurrent oral aphthous ulcers, painful, sharply margined and often associated with recurrent genital ulcers. A variety of skin lesions, such as erythema nodosum-like nodules and purpuric lesions are frequently observed. Less common manifestations of BD include thrombophlebitis, central nervous system and ocular inflammation which, however, may impact significant morbidity and mortality. The etiology is unknown, although genetic factors, infectious agents, oral and salivary microbioma, and immunologic mechanisms are implicated and studied. Topical and eventually systemic corticosteroids are the choice treatment.

Entities:  

Mesh:

Year:  2018        PMID: 29915169     DOI: 10.23736/S0026-4970.18.04135-3

Source DB:  PubMed          Journal:  Minerva Stomatol        ISSN: 0026-4970


  3 in total

1.  Clinical Effect of Non-Thermal CO2 Laser Therapy (NTCLT) on Pain Relief of Oral Aphthous Ulcers of Behçet's Disease.

Authors:  Nasrin Zand; Leila Ataie-Fashtami; Parvin Mansouri; Mohsen Fateh; Afshan Shirkavand
Journal:  J Lasers Med Sci       Date:  2021-11-07

Review 2.  Recurrent Aphthous Stomatitis: Treatment and Management.

Authors:  Marco Manfredini; Stefania Guida; Matteo Giovani; Nicola Lippolis; Enrico Spinas; Francesca Farnetani; Annunziata Dattola; Eleonora Di Matteo; Giovanni Pellacani; Luca Giannetti
Journal:  Dermatol Pract Concept       Date:  2021-09-01

Review 3.  Acquired White Oral Lesions with Specific Patterns: Oral Lichen Planus and Lupus Erythematosus.

Authors:  Marco Manfredini; Gioia Pedroni; Laura Bigi; Roberto Apponi; Alberto Murri Dello Diago; Annunziata Dattola; Francesca Farnetani; Giovanni Pellacani
Journal:  Dermatol Pract Concept       Date:  2021-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.